Literature DB >> 33654823

Photodynamic Therapy in a 3D Model of Ovarian Cancer.

Shubhankar Nath1, Kaitlin Moore2.   

Abstract

Photodynamic therapy (PDT), is a clinically-approved light-based anti-cancer treatment modality in which a photoactivatable photosensitizer is irradiated with an appropriate wavelength of light to generate cytotoxic molecules to kill cancer cells. In this article, we describe an in vitro PDT protocol using a 3-dimensional (3D) model of ovarian cancer that was established on beds of Matrigel. PDT was performed using a liposomal formulation of verteporfin photosensitizer (Visudyne®). The cancer cells were genetically-labeled with the fluorescent protein mCherry to facilitate the evaluation of the treatment response. This protocol is advantageous because the mCherry fluorescence is an indicator of cell viability, eliminating the need for external dyes, which often exhibit limited penetration and diffusion into 3D organoids. Additionally, Visudyne PDT achieves significant tumor-killing efficacy in a 3D model for ovarian cancer.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  3D model; Light-based therapies; Ovarian cancer; Photodynamic therapy; Photosensitizer; Visudyne

Year:  2019        PMID: 33654823      PMCID: PMC7854223          DOI: 10.21769/BioProtoc.3314

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  7 in total

Review 1.  Imaging and photodynamic therapy: mechanisms, monitoring, and optimization.

Authors:  Jonathan P Celli; Bryan Q Spring; Imran Rizvi; Conor L Evans; Kimberley S Samkoe; Sarika Verma; Brian W Pogue; Tayyaba Hasan
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

2.  Impact of treatment response metrics on photodynamic therapy planning and outcomes in a three-dimensional model of ovarian cancer.

Authors:  Sriram Anbil; Imran Rizvi; Jonathan P Celli; Nermina Alagic; Brian W Pogue; Tayyaba Hasan
Journal:  J Biomed Opt       Date:  2013-09       Impact factor: 3.170

Review 3.  Photonanomedicine: a convergence of photodynamic therapy and nanotechnology.

Authors:  Girgis Obaid; Mans Broekgaarden; Anne-Laure Bulin; Huang-Chiao Huang; Jerrin Kuriakose; Joyce Liu; Tayyaba Hasan
Journal:  Nanoscale       Date:  2016-06-20       Impact factor: 7.790

4.  A Combination of Visudyne and a Lipid-anchored Liposomal Formulation of Benzoporphyrin Derivative Enhances Photodynamic Therapy Efficacy in a 3D Model for Ovarian Cancer.

Authors:  Imran Rizvi; Shubhankar Nath; Girgis Obaid; Mustafa Kemal Ruhi; Kaitlin Moore; Shazia Bano; David Kessel; Tayyaba Hasan
Journal:  Photochem Photobiol       Date:  2019-01-07       Impact factor: 3.421

5.  Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer.

Authors:  Imran Rizvi; Jonathan P Celli; Conor L Evans; Adnan O Abu-Yousif; Alona Muzikansky; Brian W Pogue; Dianne Finkelstein; Tayyaba Hasan
Journal:  Cancer Res       Date:  2010-11-09       Impact factor: 12.701

6.  Treatment of ovarian cancer with photodynamic therapy and immunoconjugates in a murine ovarian cancer model.

Authors:  B A Goff; J Blake; M P Bamberg; T Hasan
Journal:  Br J Cancer       Date:  1996-10       Impact factor: 7.640

7.  An imaging-based platform for high-content, quantitative evaluation of therapeutic response in 3D tumour models.

Authors:  Jonathan P Celli; Imran Rizvi; Adam R Blanden; Iqbal Massodi; Michael D Glidden; Brian W Pogue; Tayyaba Hasan
Journal:  Sci Rep       Date:  2014-01-17       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.